Chaitanya Tellapragada

Chaitanya Tellapragada Achyutha Krishna

Research specialist

Research description

Recent Publications: 

Recurrent bacteremia with Enterococcus faecalis, the clinical findings predicting endocarditis, and genomic characterization of the isolates: a retrospective cohort study.
Tellapragada C, Östlund H, Giske C, Rasmussen M, Berge A
Eur J Clin Microbiol Infect Dis 2023 Aug;42(8):1001-1009

Therapeutic-oligonucleotides activated by nucleases (TOUCAN): A nanocarrier system for the specific delivery of clinical nucleoside analogues.
Borsa BA, Hernandez LI, Jiménez T, Tellapragada C, Giske CG, Hernandez FJ
J Control Release 2023 Aug;361():260-269

Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens.
Antonelli A, Coppi M, Tellapragada C, Hasan B, Maruri A, Gijón D, Morecchiato F, de Vogel C, Verbon A, van Wamel W, Kragh KN, Frimodt-Møller N, Cantón R, Giske CG, Rossolini GM
Int J Antimicrob Agents 2022 Oct;60(4):106668

Environmental Factors Associated With Soil Prevalence of the Melioidosis Pathogen Burkholderia pseudomallei: A Longitudinal Seasonal Study From South West India.
Shaw T, Assig K, Tellapragada C, Wagner GE, Choudhary M, Göhler A, Eshwara VK, Steinmetz I, Mukhopadhyay C
Front Microbiol 2022 ;13():902996

Evaluation of a pneumonia multiplex PCR panel for detection of bacterial respiratory tract pathogens from serial specimens collected from hospitalized COVID-19 patients.
Tellapragada C, Ydsten KA, Ternhag A, Giske CG
Eur J Clin Microbiol Infect Dis 2022 Jul;41(7):1093-1098

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system.
Punekar M, Kshirsagar M, Tellapragada C, Patil K
Microb Pathog 2022 Jul;168():105608

Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women.
Munusamy Ponnan S, Thiruvengadam K, Tellapragada C, Ambikan AT, Narayanan A, Kathirvel S, Mathayan M, Shankar J, Rajaraman A, Afshan Amanulla M, Dinesha TR, Poongulali S, Saravanan S, Murugavel KG, Swaminathan S, Velu V, Shacklett B, Neogi U, Hanna LE
Microbiol Spectr 2021 Oct;9(2):e0047021

New evidence for managing Gram-negative bloodstream infections.
Nutman A, Tellapragada C, Giske CG, Yahav D
Curr Opin Infect Dis 2021 Dec;34(6):599-610

In Vitro Activity of Omadacycline and Five Comparators against Contemporary Ribotypes of Clostridioides difficile in Stockholm, Sweden.
Camporeale A, Tellapragada C, Kornijenko J, Nord CE, Giske CG
Microbiol Spectr 2021 Oct;9(2):e0144021

The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients.
Tellapragada C, Giske CG
Eur J Clin Microbiol Infect Dis 2021 Dec;40(12):2479-2485

Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening.
Kragh KN, Gijón D, Maruri A, Antonelli A, Coppi M, Kolpen M, Crone S, Tellapragada C, Hasan B, Radmer S, de Vogel C, van Wamel W, Verbon A, Giske CG, Rossolini GM, Cantón R, Frimodt-Møller N
J Antimicrob Chemother 2021 03;76(4):1001-1009

Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study.
Tellapragada C, Hasan B, Antonelli A, Maruri A, de Vogel C, Gijón D, Coppi M, Verbon A, van Wamel W, Rossolini GM, Cantón R, Giske CG
Clin Microbiol Infect 2020 Oct;26(10):1413.e1-1413.e7